China Regenerative Medicine International (HKSE:08158) Effective Interest Rate on Debt % : 0.00% (As of Jun. 2024)

View and export this data going back to 2001. Start your Free Trial

What is China Regenerative Medicine International Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. China Regenerative Medicine International's annualized positive value of Interest Expense for the quarter that ended in Jun. 2024 was HK$0.00 Mil. China Regenerative Medicine International's average total debt for the quarter that ended in Jun. 2024 was HK$50.54 Mil. Therefore, China Regenerative Medicine International's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2024 was 0.00%.

China Regenerative Medicine International Effective Interest Rate on Debt % Historical Data

The historical data trend for China Regenerative Medicine International's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Regenerative Medicine International Effective Interest Rate on Debt % Chart

China Regenerative Medicine International Annual Data

Trend

Apr15

Apr16

Apr17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

10.43

1.86

1.45

1.60

2.18

China Regenerative Medicine International Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															1.44	1.24	1.76	-	-

Competitive Comparison of China Regenerative Medicine International's Effective Interest Rate on Debt %

For the Biotechnology subindustry, China Regenerative Medicine International's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Regenerative Medicine International's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, China Regenerative Medicine International's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where China Regenerative Medicine International's Effective Interest Rate on Debt % falls into.

Save Embed

;

Save Embed

;

China Regenerative Medicine International Effective Interest Rate on Debt % Calculation

China Regenerative Medicine International's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2022 )	+	Total Debt (A: Dec. 2023 ))	/ count )
=	-1 * -0.979	/	( (72.012	+	50.191)	/ 2 )
=	-1 * -0.979	/	61.1015
=	1.60 %

where

	Total Debt (A: Dec. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	13.682	+	58.33
=	72.012

	Total Debt (A: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	26.167	+	24.024
=	50.191

China Regenerative Medicine International's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2024 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Dec. 2023 )	+	Total Debt (Q: Jun. 2024 ))	/ count )
=	-1 * 0	/	( (50.191	+	50.879)	/ 2 )
=	-1 * 0	/	50.535
=	0.00 %

where

	Total Debt (Q: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	26.167	+	24.024
=	50.191

	Total Debt (Q: Jun. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	21.579	+	29.3
=	50.879

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Jun. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

China Regenerative Medicine International (HKSE:08158) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

China Regenerative Medicine International Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of China Regenerative Medicine International's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

China Regenerative Medicine International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » China Regenerative Medicine International Ltd (HKSE:08158) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

N/A

Address

132 Nathan Road, Suite 2310-18, Miramar Tower, Tsim Sha Tsui, Kowloon, HKG

Website

https://www.crmi.hk

China Regenerative Medicine International Ltd is an investment holding company engaged in the provision of healthcare products and services. Its reportable segments are Aesthetic medical and beauty services and Medical services. The vast majority of the company's revenue is derived from its Aesthetic medical and beauty services segment. Geographically, the People's Republic of China accounts for the majority of the revenue. It also has a presence in Hong Kong.

Executives

Central Huijin Investment Ltd.	2201 Interest of corporation controlled by you
Wang Chuang	2101 Beneficial owner
Arab Osman Mohammed	2501 Other
Wong Kwok Keung	2501 Other
Lei Changjuan	2101 Beneficial owner
Chang Zhou Shi Zhong Min Xing Kong Qi Ye Guan Li Zi Xun Fu Wu He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Kong Yudong	2101 Beneficial owner
Chang Zhou Shi Yao Guang Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Li Ren	2201 Interest of corporation controlled by you
Nat-ace Wood Industry Ltd. (formerly Known As Forerunner Technology Limited)	2201 Interest of corporation controlled by you
All Favour Holdings Limited	2101 Beneficial owner
Deng Shufen	2202 Interest of your spouse
Dai Yumin	2201 Interest of corporation controlled by you
Wang Xiaogang	2101 Beneficial owner
China Orient Asset Management Co., Ltd.	2106 Person having a security interest in shares

China Regenerative Medicine International Headlines

No Headlines